The George Washington Cancer Institute | Strategic Alliance Partners

Latest from The George Washington Cancer Institute

Dr. Smith on PI3K Inhibitors in CLL

November 02, 2019

Mitchell R. Smith, MD, PhD, division director, Cancer and Blood Disorders, and professor of medicine, GW Cancer Center, discusses the use of PI3K inhibitors in chronic lymphocytic leukemia (CLL).

Improving CAR T-Cell Therapies With Greater Understanding of Cancer Immunology

October 08, 2019

Eduardo Sotomayor, MD, discusses the evolution of CAR T-cell therapy, adverse events that require careful monitoring, and novel strategies under development that may mitigate toxicity and improve T-cell persistence.

Dr. Sotomayor on the Durability of CAR T Cells in Hematologic Malignancies

October 04, 2019

Eduardo Sotomayor, MD, professor of medicine, Department of Hematology and Oncology, and director, GW Cancer Center, discusses the durability of CAR T cells, as well as ways to combat immune escape mechanisms in hematologic malignancies.